Plasmodium gallinaceum: avian screen for drugs with radical curative properties.
Existing primary screens for radical curative antimalarial drugs fail to adequately detect many compounds which affect the latent, exoerythrocytic hypnozoite, the stage of the parasite responsible for relapse. At the same time, these screens falsely identify a wide range of compounds with no radical curative activity. The avian malaria, Plasmodium gallinaceum, and Aedes aegypti mosquitos were used in a screen which measures the effects of candidate compounds on gametocytes and their development within the mosquito. Sporontocidal and gametocytocidal effects could be differentiated by this screen. In a blind study, those compounds shown to be exclusively gametocytocidal were those same drugs which had previously been shown to have radical curative effects against true relapsing malarias. The chicken malaria gametocyte screen was more sensitive than the rodent screens in detecting useful compounds, with a minimum of false positive identifications.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D002645:Chickens; D002738:Chloroquine / Q000031:analogs & derivatives / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D008289:Malaria, Avian / Q000188:drug therapy*; D010961:Plasmodium / Q000187:drug effects* / Q000254:growth & development; D011319:Primaquine / Q000494:pharmacology; D011739:Pyrimethamine / Q000494:pharmacology
D000962:Antimalarials; C023676:chloroquine diphosphate; D002738:Chloroquine; D011319:Primaquine; D011739:Pyrimethamine